z-logo
Premium
High and low vitamin D level is associated with cardiovascular autonomic neuropathy in people with Type 1 and Type 2 diabetes
Author(s) -
Hansen C. S.,
Fleischer J.,
Vistisen D.,
Ridderstråle M.,
Jensen J. S.,
Jørgensen M. E.
Publication year - 2017
Publication title -
diabetic medicine
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.474
H-Index - 145
eISSN - 1464-5491
pISSN - 0742-3071
DOI - 10.1111/dme.13269
Subject(s) - medicine , type 2 diabetes , autonomic neuropathy , vitamin d and neurology , diabetes mellitus , type 1 diabetes , endocrinology , diabetic neuropathy , pediatrics , biology , genetics , cell culture , neuroblastoma
Aim To investigate the possible association between vitamin D deficiency and cardiovascular autonomic neuropathy in people with diabetes. Methods A total of 113 people with Type 1 or Type 2 diabetes [mean (interquartile range) diabetes duration 22.0 (12–31) years, mean ( sd ) age 56.2 (13.0) years, 58% men] underwent vitamin D (D2 and D3) assessment, and were screened for cardiovascular autonomic neuropathy using three cardiovascular reflex tests [heart rate response to deep breathing (E/I ratio), to standing (30/15 ratio) and to the Valsalva manoeuvre] and assessment of 5‐min resting heart rate and heart rate variability indices. Results We found an inverse U‐shaped association between serum vitamin D level and E/I ratio, 30/15 ratio and three heart rate variability indices ( P < 0.05). Vitamin D level was non‐linearly associated with cardiovascular autonomic neuropathy diagnosis ( P < 0.05 adjusted for age and sex). Linear regression models showed that an increase in vitamin D level from 25 to 50 nmol/l was associated with an increase of 3.9% (95% CI 0.1;7.9) in E/I ratio and 4.8% (95% CI 4.7;9.3) in 30/15 ratio. Conversely, an increase from 125 to 150 nmol/l in vitamin D level was associated with a decrease of 2.6% (95% CI −5.8;0.1) and 4.1% (95% CI −5.8;−0.5) in the respective outcome measures. Conclusions High and low vitamin D levels were associated with cardiovascular autonomic neuropathy in people with diabetes. Future studies should explore this association and the efficacy of treating dysvitaminosis D to prevent cardiovascular autonomic neuropathy.

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom